| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | NEBL MAP1A KIF1A IQGAP2 NME8 RCAN3 KIF3A MPRIP SHROOM4 BICDL1 SETD2 AFAP1 DLC1 PHACTR4 STAU2 DIAPH1 DIAPH2 NAV3 MACF1 TAOK1 DMD DYNC1I1 KIF2C | 1.09e-05 | 1099 | 153 | 23 | GO:0008092 |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.61e-05 | 70 | 153 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.98e-04 | 118 | 153 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | phosphodiesterase I activity | 5.75e-04 | 5 | 153 | 2 | GO:0004528 | |
| GeneOntologyMolecularFunction | histone H3K36 trimethyltransferase activity | 5.75e-04 | 5 | 153 | 2 | GO:0140955 | |
| GeneOntologyMolecularFunction | sodium channel activity | 6.74e-04 | 52 | 153 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 6.74e-04 | 52 | 153 | 4 | GO:0042169 | |
| GeneOntologyMolecularFunction | nucleoside monophosphate kinase activity | 6.98e-04 | 23 | 153 | 3 | GO:0050145 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.01e-03 | 26 | 153 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | actin binding | NEBL MAP1A IQGAP2 MPRIP SHROOM4 AFAP1 PHACTR4 DIAPH1 DIAPH2 MACF1 DMD | 1.19e-03 | 479 | 153 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | POU domain binding | 1.19e-03 | 7 | 153 | 2 | GO:0070974 | |
| GeneOntologyBiologicalProcess | microtubule-based process | BICDL2 SPAG1 CEP85 MCPH1 MAP1A KIF1A DYNC2H1 ASH1L BMERB1 NME8 KIF3A FSIP2 BICDL1 SETD2 CFAP221 DNAH17 CCNL1 STAU2 DIAPH1 NAV3 TMF1 MACF1 TAOK1 SPAG17 DYNC1I1 KIF2C | 5.91e-08 | 1058 | 152 | 26 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule-based movement | BICDL2 MAP1A KIF1A DYNC2H1 ASH1L NME8 KIF3A FSIP2 BICDL1 CFAP221 DNAH17 STAU2 TMF1 SPAG17 DYNC1I1 KIF2C | 7.71e-07 | 493 | 152 | 16 | GO:0007018 |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription initiation | 1.60e-06 | 77 | 152 | 7 | GO:2000144 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription initiation | 4.96e-06 | 91 | 152 | 7 | GO:2000142 | |
| GeneOntologyBiologicalProcess | microtubule-based protein transport | 6.26e-06 | 17 | 152 | 4 | GO:0099118 | |
| GeneOntologyBiologicalProcess | protein transport along microtubule | 6.26e-06 | 17 | 152 | 4 | GO:0098840 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | SETX APEX1 POU5F1 POU5F1B GTF3C1 BAZ2A MDC1 TAF4 TAF4B TAF12 | 8.56e-06 | 231 | 152 | 10 | GO:0006352 |
| GeneOntologyBiologicalProcess | positive regulation of transcription initiation by RNA polymerase II | 1.29e-05 | 70 | 152 | 6 | GO:0060261 | |
| GeneOntologyBiologicalProcess | transport along microtubule | BICDL2 MAP1A KIF1A DYNC2H1 KIF3A BICDL1 STAU2 SPAG17 DYNC1I1 | 1.59e-05 | 197 | 152 | 9 | GO:0010970 |
| GeneOntologyBiologicalProcess | microtubule-based transport | BICDL2 MAP1A KIF1A DYNC2H1 KIF3A BICDL1 CFAP221 STAU2 SPAG17 DYNC1I1 | 1.88e-05 | 253 | 152 | 10 | GO:0099111 |
| GeneOntologyBiologicalProcess | regulation of transcription initiation by RNA polymerase II | 2.99e-05 | 81 | 152 | 6 | GO:0060260 | |
| GeneOntologyBiologicalProcess | vesicle transport along microtubule | 3.64e-05 | 51 | 152 | 5 | GO:0047496 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | BICDL2 MAP1A KIF1A DYNC2H1 KIF3A BICDL1 STAU2 SPAG17 DYNC1I1 | 4.53e-05 | 225 | 152 | 9 | GO:0030705 |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 1.27e-04 | 66 | 152 | 5 | GO:0007019 | |
| GeneOntologyBiologicalProcess | vesicle cytoskeletal trafficking | 1.36e-04 | 67 | 152 | 5 | GO:0099518 | |
| GeneOntologyBiologicalProcess | cilium movement | 1.41e-04 | 261 | 152 | 9 | GO:0003341 | |
| GeneOntologyBiologicalProcess | Golgi to secretory granule transport | 1.61e-04 | 3 | 152 | 2 | GO:0055107 | |
| GeneOntologyBiologicalProcess | trophectodermal cell fate commitment | 1.61e-04 | 3 | 152 | 2 | GO:0001830 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 1.72e-04 | 38 | 152 | 4 | GO:0007026 | |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 2.55e-04 | 42 | 152 | 4 | GO:0031114 | |
| GeneOntologyBiologicalProcess | neuron projection retraction | 3.21e-04 | 4 | 152 | 2 | GO:0106028 | |
| GeneOntologyBiologicalProcess | multicellular organismal locomotion | 3.21e-04 | 4 | 152 | 2 | GO:0071965 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 3.32e-04 | 293 | 152 | 9 | GO:0032886 | |
| GeneOntologyBiologicalProcess | neuron projection organization | 3.60e-04 | 127 | 152 | 6 | GO:0106027 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 4.62e-04 | 87 | 152 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 4.67e-04 | 186 | 152 | 7 | GO:0006367 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | MAP1A KIF1A DYNC2H1 DZIP1L NME8 KIF3A CFAP221 DNAH17 STAU2 SPAG17 DYNC1I1 | 2.13e-05 | 317 | 152 | 11 | GO:0032838 |
| GeneOntologyCellularComponent | microtubule associated complex | 2.38e-05 | 161 | 152 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MAP1A KIF1A IQGAP2 DYNC2H1 KRT84 KIF3A SHROOM4 AFAP1 DLC1 DNAH17 STAU2 DIAPH1 DIAPH2 NAV3 MACF1 DMD SPAG17 DYNC1I1 KIF2C | 2.96e-05 | 899 | 152 | 19 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | NEBL MAP1A KIF1A IQGAP2 DYNC2H1 KRT84 CMYA5 KIF3A SHROOM4 AFAP1 DLC1 SCN1A DNAH17 STAU2 DIAPH1 DIAPH2 NAV3 MACF1 DMD SPAG17 DYNC1I1 KIF2C | 4.43e-05 | 1179 | 152 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | NEBL MAP1A KIF1A IQGAP2 DYNC2H1 KRT84 CMYA5 KIF3A SHROOM4 AFAP1 DLC1 SCN1A DNAH17 STAU2 DIAPH1 DIAPH2 NAV3 MACF1 DMD SPAG17 DYNC1I1 KIF2C | 4.90e-05 | 1187 | 152 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | cytoplasmic region | MAP1A KIF1A DYNC2H1 DZIP1L NME8 KIF3A CFAP221 DNAH17 STAU2 SPAG17 DYNC1I1 | 6.75e-05 | 360 | 152 | 11 | GO:0099568 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.38e-04 | 17 | 152 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | microtubule | MAP1A KIF1A IQGAP2 DYNC2H1 KIF3A DNAH17 STAU2 NAV3 MACF1 SPAG17 DYNC1I1 KIF2C | 5.36e-04 | 533 | 152 | 12 | GO:0005874 |
| GeneOntologyCellularComponent | dynein complex | 6.41e-04 | 54 | 152 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | axoneme | 8.13e-04 | 207 | 152 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 8.36e-04 | 208 | 152 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.12e-03 | 107 | 152 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.12e-03 | 107 | 152 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.20e-03 | 29 | 152 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | axon initial segment | 1.20e-03 | 29 | 152 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 1.26e-03 | 110 | 152 | 5 | GO:0120111 | |
| GeneOntologyCellularComponent | axon cytoplasm | 1.52e-03 | 68 | 152 | 4 | GO:1904115 | |
| GeneOntologyCellularComponent | actomyosin | 1.66e-03 | 117 | 152 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 1.72e-03 | 118 | 152 | 5 | GO:0032432 | |
| Domain | ZnF_C2HC | 3.71e-06 | 55 | 142 | 6 | SM00343 | |
| Domain | Znf_CCHC | 3.71e-06 | 55 | 142 | 6 | IPR001878 | |
| Domain | Na_channel_asu | 4.97e-05 | 10 | 142 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 4.97e-05 | 10 | 142 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 4.97e-05 | 10 | 142 | 3 | PF06512 | |
| Domain | TAF4 | 5.74e-05 | 2 | 142 | 2 | PF05236 | |
| Domain | TAF4 | 5.74e-05 | 2 | 142 | 2 | IPR007900 | |
| Domain | Drf_DAD | 1.71e-04 | 3 | 142 | 2 | PF06345 | |
| Domain | Drf_DAD | 1.71e-04 | 3 | 142 | 2 | IPR010465 | |
| Domain | POU_dom_5 | 1.71e-04 | 3 | 142 | 2 | IPR015585 | |
| Domain | IQ | 3.81e-04 | 81 | 142 | 5 | SM00015 | |
| Domain | AWS | 5.65e-04 | 5 | 142 | 2 | SM00570 | |
| Domain | TAFH | 5.65e-04 | 5 | 142 | 2 | SM00549 | |
| Domain | AWS | 5.65e-04 | 5 | 142 | 2 | PS51215 | |
| Domain | AWS_dom | 5.65e-04 | 5 | 142 | 2 | IPR006560 | |
| Domain | TAFH_NHR1 | 5.65e-04 | 5 | 142 | 2 | IPR003894 | |
| Domain | DDE_Tnp_1_7 | 5.65e-04 | 5 | 142 | 2 | PF13843 | |
| Domain | TAFH | 5.65e-04 | 5 | 142 | 2 | PS51119 | |
| Domain | PGBD | 5.65e-04 | 5 | 142 | 2 | IPR029526 | |
| Domain | TAFH | 5.65e-04 | 5 | 142 | 2 | PF07531 | |
| Domain | WW_DOMAIN_1 | 6.07e-04 | 51 | 142 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 6.07e-04 | 51 | 142 | 4 | PS50020 | |
| Domain | IQ_motif_EF-hand-BS | 6.20e-04 | 90 | 142 | 5 | IPR000048 | |
| Domain | WW_dom | 6.53e-04 | 52 | 142 | 4 | IPR001202 | |
| Domain | IQ | 7.19e-04 | 93 | 142 | 5 | PS50096 | |
| Domain | P-loop_NTPase | SETX SAMD9 KIF1A DYNC2H1 MAGI3 AK9 NLRP2 MFN1 KIF3A RAD50 LRRIQ1 GIMAP8 NAV3 CARD11 GNAL KIF2C | 7.31e-04 | 848 | 142 | 16 | IPR027417 |
| Domain | - | 8.44e-04 | 6 | 142 | 2 | 2.40.50.90 | |
| Domain | Na_trans_cytopl | 8.44e-04 | 6 | 142 | 2 | PF11933 | |
| Domain | Staphylococal_nuclease_OB-fold | 8.44e-04 | 6 | 142 | 2 | IPR016071 | |
| Domain | Na_trans_cytopl | 8.44e-04 | 6 | 142 | 2 | IPR024583 | |
| Domain | Channel_four-helix_dom | 9.26e-04 | 57 | 142 | 4 | IPR027359 | |
| Domain | - | 9.26e-04 | 57 | 142 | 4 | 1.20.120.350 | |
| Domain | TUDOR | 1.10e-03 | 27 | 142 | 3 | SM00333 | |
| Domain | - | 1.10e-03 | 27 | 142 | 3 | 1.10.260.40 | |
| Domain | Lambda_DNA-bd_dom | 1.36e-03 | 29 | 142 | 3 | IPR010982 | |
| Domain | Tudor | 1.50e-03 | 30 | 142 | 3 | IPR002999 | |
| Domain | CH | 1.51e-03 | 65 | 142 | 4 | SM00033 | |
| Domain | DAD_dom | 1.56e-03 | 8 | 142 | 2 | IPR014767 | |
| Domain | DAD | 1.56e-03 | 8 | 142 | 2 | PS51231 | |
| Domain | Ion_trans_dom | 1.79e-03 | 114 | 142 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.79e-03 | 114 | 142 | 5 | PF00520 | |
| Domain | CH | 1.99e-03 | 70 | 142 | 4 | PF00307 | |
| Domain | Drf_GBD | 2.00e-03 | 9 | 142 | 2 | PF06371 | |
| Domain | Drf_FH3 | 2.00e-03 | 9 | 142 | 2 | PF06367 | |
| Domain | FH3_dom | 2.00e-03 | 9 | 142 | 2 | IPR010472 | |
| Domain | GTPase-bd | 2.00e-03 | 9 | 142 | 2 | IPR010473 | |
| Domain | Drf_FH3 | 2.00e-03 | 9 | 142 | 2 | SM01139 | |
| Domain | Drf_GBD | 2.00e-03 | 9 | 142 | 2 | SM01140 | |
| Domain | - | 2.10e-03 | 71 | 142 | 4 | 1.10.418.10 | |
| Domain | CH | 2.32e-03 | 73 | 142 | 4 | PS50021 | |
| Domain | CH-domain | 2.56e-03 | 75 | 142 | 4 | IPR001715 | |
| Domain | GBD/FH3_dom | 3.02e-03 | 11 | 142 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 3.02e-03 | 11 | 142 | 2 | PS51232 | |
| Domain | Kinesin_motor_CS | 3.71e-03 | 41 | 142 | 3 | IPR019821 | |
| Domain | SAM_2 | 4.25e-03 | 43 | 142 | 3 | PF07647 | |
| Domain | Kinesin-like_fam | 4.25e-03 | 43 | 142 | 3 | IPR027640 | |
| Domain | - | 4.54e-03 | 44 | 142 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 4.54e-03 | 44 | 142 | 3 | PF00225 | |
| Domain | KISc | 4.54e-03 | 44 | 142 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 4.54e-03 | 44 | 142 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 4.54e-03 | 44 | 142 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 4.54e-03 | 44 | 142 | 3 | PS50067 | |
| Domain | TUDOR | 4.92e-03 | 14 | 142 | 2 | PF00567 | |
| Domain | WW | 5.46e-03 | 47 | 142 | 3 | PF00397 | |
| Domain | FH2 | 5.65e-03 | 15 | 142 | 2 | PS51444 | |
| Domain | FH2_Formin | 5.65e-03 | 15 | 142 | 2 | IPR015425 | |
| Domain | FH2 | 5.65e-03 | 15 | 142 | 2 | PF02181 | |
| Domain | FH2 | 5.65e-03 | 15 | 142 | 2 | SM00498 | |
| Domain | WW | 5.80e-03 | 48 | 142 | 3 | SM00456 | |
| Domain | POU | 6.42e-03 | 16 | 142 | 2 | SM00352 | |
| Domain | Post-SET_dom | 6.42e-03 | 16 | 142 | 2 | IPR003616 | |
| Domain | POU_dom | 6.42e-03 | 16 | 142 | 2 | IPR000327 | |
| Domain | PostSET | 6.42e-03 | 16 | 142 | 2 | SM00508 | |
| Domain | Pou | 6.42e-03 | 16 | 142 | 2 | PF00157 | |
| Domain | POU_1 | 6.42e-03 | 16 | 142 | 2 | PS00035 | |
| Domain | POU_2 | 6.42e-03 | 16 | 142 | 2 | PS00465 | |
| Domain | POU_3 | 6.42e-03 | 16 | 142 | 2 | PS51179 | |
| Domain | POST_SET | 6.42e-03 | 16 | 142 | 2 | PS50868 | |
| Domain | EF-hand-dom_pair | 6.43e-03 | 287 | 142 | 7 | IPR011992 | |
| Domain | POU | 7.24e-03 | 17 | 142 | 2 | IPR013847 | |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 2.18e-05 | 81 | 99 | 6 | M39490 | |
| Pubmed | FAM90A14 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 2.31e-22 | 25 | 157 | 12 | 17684299 | |
| Pubmed | FAM90A14 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.43e-20 | 23 | 157 | 11 | 18602769 | |
| Pubmed | SETX RARS1 NEBL SFSWAP KIF1A MINK1 APEX1 CGGBP1 ANKHD1 MPRIP SETD2 AFAP1 PXDN SND1 BAZ2A RRS1 EIF4B MDC1 CCNL1 STAU2 RBM6 TMF1 MACF1 SCAF11 TAF4 PATJ KIF2C | 7.82e-10 | 1497 | 157 | 27 | 31527615 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | PAG1 SPAG1 RARS1 NEBL MINK1 MAGI3 LRRC59 NLRP2 MPRIP SND1 EIF4B PHACTR4 MACF1 PATJ ACBD3 SNX1 VCPIP1 | 9.06e-10 | 565 | 157 | 17 | 25468996 |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A26 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A10 | 4.26e-09 | 164 | 157 | 10 | 22967998 |
| Pubmed | FLG SETX CEP85 RARS1 ARID4B PCDH11Y HNRNPM PSMD1 CMYA5 VPS13D EIF4B PATJ | 5.61e-09 | 277 | 157 | 12 | 30745168 | |
| Pubmed | FLG SCN11A SPAG1 IQGAP2 KRT84 DZIP1L ASH1L HNRNPM MAGI3 PSMD1 LRRC59 RNF17 PXDN GTF3C1 SND1 RRS1 FAM186A EIF4B MACF1 TAF4 DMD SPAG17 USP1 DYNC1I1 UTP14C | 7.90e-09 | 1442 | 157 | 25 | 35575683 | |
| Pubmed | FLG DYNC2H1 SPTLC1 APEX1 RNF17 RAD50 SETD2 RGS6 RRS1 EIF4B MDC1 RBM6 GNAL DMD TAF12 ACBD3 SNX1 KIF2C | 1.05e-08 | 754 | 157 | 18 | 35906200 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ARID4B SFSWAP MINK1 TATDN2 PSMD1 RAD50 STK10 SETD2 GTF3C1 BAZ2A EIF4B MDC1 CCNL1 PHACTR4 RBM6 TAOK1 SCAF11 VCPIP1 | 1.57e-08 | 774 | 157 | 18 | 15302935 |
| Pubmed | CEP85 RARS1 ANKHD1 MPRIP RAD50 SETD2 GTF3C1 SND1 BAZ2A MDC1 PHACTR4 TAF4 PATJ SNX1 VCPIP1 | 3.32e-08 | 549 | 157 | 15 | 38280479 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SETX CEP85 MAP1A DYNC2H1 MPRIP RAD50 SETD2 DIAPH1 RBM6 MACF1 CLSPN PATJ ZMYM6 KIF2C VCPIP1 | 8.10e-08 | 588 | 157 | 15 | 38580884 |
| Pubmed | TAF4b and TAF4 differentially regulate mouse embryonic stem cells maintenance and proliferation. | 9.02e-08 | 3 | 157 | 3 | 23350932 | |
| Pubmed | Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms. | 3.60e-07 | 4 | 157 | 3 | 26637798 | |
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 19635797 | ||
| Pubmed | CEP85 KIF1A ENPP2 ASH1L MAGI3 PSMD1 SPOCK2 CMYA5 FRMD4B KIF3A MPRIP JAK1 ZNF655 NAV3 MACF1 TAOK1 TAF12 ACBD3 SNX1 DYNC1I1 VCPIP1 | 3.71e-07 | 1285 | 157 | 21 | 35914814 | |
| Pubmed | SETX IQGAP2 KRT84 DZIP1L ASH1L PSMD1 SPOCK2 ANKHD1 RCOR1 ZNF655 EIF4B CCNL1 DIAPH1 MACF1 TAOK1 PATJ CPLANE1 KIF2C UTP14C | 4.95e-07 | 1084 | 157 | 19 | 11544199 | |
| Pubmed | ARID4B SFSWAP MAP1A ASH1L HNRNPM SPTLC1 ANKHD1 RAD50 JAK1 SETD2 RCOR1 TCHH BAZ2A DIAPH1 MACF1 TAF4 TAF4B CLSPN TAF12 | 7.65e-07 | 1116 | 157 | 19 | 31753913 | |
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 37900284 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NEBL MAP1A HNRNPM LRRC59 ANKHD1 MPRIP RAD50 SETD2 SND1 BAZ2A RRS1 EIF4B STAU2 MACF1 ACBD3 SNX1 VCPIP1 | 1.24e-06 | 934 | 157 | 17 | 33916271 |
| Pubmed | 1.29e-06 | 234 | 157 | 9 | 36243803 | ||
| Pubmed | Direct Reprogramming of Mouse Fibroblasts into Functional Skeletal Muscle Progenitors. | 1.79e-06 | 6 | 157 | 3 | 29742392 | |
| Pubmed | 2.32e-06 | 187 | 157 | 8 | 26460568 | ||
| Pubmed | TAF4b transcription networks regulating early oocyte differentiation. | 3.12e-06 | 7 | 157 | 3 | 35043944 | |
| Pubmed | 3.16e-06 | 50 | 157 | 5 | 27026076 | ||
| Pubmed | PAG1 MINK1 SPTLC1 MPRIP STK10 PHACTR4 MACF1 DMD CDH2 ACBD3 SNX1 | 3.70e-06 | 421 | 157 | 11 | 36976175 | |
| Pubmed | 3.96e-06 | 24 | 157 | 4 | 32521258 | ||
| Pubmed | 4.97e-06 | 8 | 157 | 3 | 15601843 | ||
| Pubmed | 7.43e-06 | 9 | 157 | 3 | 17138661 | ||
| Pubmed | 7.43e-06 | 9 | 157 | 3 | 16382098 | ||
| Pubmed | 8.53e-06 | 61 | 157 | 5 | 20548051 | ||
| Pubmed | KIF1A POLA1 PSMD1 ANKHD1 RAD50 GTF3C1 SND1 BAZ2A RRS1 MDC1 RBM6 MACF1 SCAF11 | 9.20e-06 | 653 | 157 | 13 | 22586326 | |
| Pubmed | 1.06e-05 | 10 | 157 | 3 | 23521771 | ||
| Pubmed | CEP85 SAMD9 MAP1A POLA1 LRRC59 RAD50 STK10 AFAP1 CCNL1 MACF1 ACBD3 | 1.08e-05 | 472 | 157 | 11 | 38943005 | |
| Pubmed | 1.14e-05 | 31 | 157 | 4 | 19690177 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MCPH1 KIF1A MINK1 TRPM2 PCDH11Y ASH1L MAGI3 PSMD1 ST3GAL1 STK10 UBE2J2 PXDN GTF3C1 KCND3 CLK2 RBM6 MACF1 SCAF11 TAF4 PATJ | 1.35e-05 | 1489 | 157 | 20 | 28611215 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | FLG ASXL1 DYNC2H1 POLA1 KRT84 MAGI3 PSMD1 LRRC59 KIF3A RAD50 SND1 EIF4B GNAL USP1 ZMYM6 VCPIP1 | 1.38e-05 | 1005 | 157 | 16 | 19615732 |
| Pubmed | SETX ARID4B MAP1A HNRNPM PSMD1 KIF3A DIAPH2 NAV3 MACF1 DMD CPLANE1 | 1.42e-05 | 486 | 157 | 11 | 20936779 | |
| Pubmed | 1.45e-05 | 11 | 157 | 3 | 17360631 | ||
| Pubmed | The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. | 1.45e-05 | 11 | 157 | 3 | 16815997 | |
| Pubmed | 1.45e-05 | 11 | 157 | 3 | 31835801 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RARS1 IQGAP2 HNRNPM APEX1 PSMD1 LRRC59 ANKHD1 RAD50 LRRIQ1 GTF3C1 SND1 EIF4B STAU2 DIAPH1 MACF1 PATJ ACBD3 | 1.88e-05 | 1149 | 157 | 17 | 35446349 |
| Pubmed | Essential and overlapping functions for mammalian Argonautes in microRNA silencing. | 1.93e-05 | 12 | 157 | 3 | 19174539 | |
| Pubmed | 1.93e-05 | 12 | 157 | 3 | 17913791 | ||
| Pubmed | FLG RARS1 HNRNPM CGGBP1 ANKHD1 MPRIP RAD50 JAK1 GTF3C1 MACF1 TAOK1 SCAF11 | 1.99e-05 | 601 | 157 | 12 | 33658012 | |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 2.02e-05 | 182 | 157 | 7 | 30711629 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 15685634 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 16950240 | ||
| Pubmed | Maternal Oct-4 is a potential key regulator of the developmental competence of mouse oocytes. | 2.02e-05 | 2 | 157 | 2 | 18837968 | |
| Pubmed | Cruciform Formable Sequences within Pou5f1 Enhancer Are Indispensable for Mouse ES Cell Integrity. | 2.02e-05 | 2 | 157 | 2 | 33810223 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 28988986 | ||
| Pubmed | Abnormal DNA methylation of the Oct-4 enhancer region in cloned mouse embryos. | 2.02e-05 | 2 | 157 | 2 | 18932201 | |
| Pubmed | A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. | 2.02e-05 | 2 | 157 | 2 | 1972777 | |
| Pubmed | Mouse Oct-3 maps between the tcl12 embryonic lethal gene and the Qa gene in the H-2 complex. | 2.02e-05 | 2 | 157 | 2 | 1680810 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 2.02e-05 | 2 | 157 | 2 | 10827969 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 15996113 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 26804242 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 21502535 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 11839818 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 30333224 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 19694741 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 31743419 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 33221301 | ||
| Pubmed | Developmental fate of embryonic germ cells (EGCs), in vivo and in vitro. | 2.02e-05 | 2 | 157 | 2 | 12641567 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 14992721 | ||
| Pubmed | A nontranscriptional role for Oct4 in the regulation of mitotic entry. | 2.02e-05 | 2 | 157 | 2 | 25324523 | |
| Pubmed | Novel variants of Oct-3/4 gene expressed in mouse somatic cells. | 2.02e-05 | 2 | 157 | 2 | 18765667 | |
| Pubmed | Oct4 dependence of chromatin structure within the extended Nanog locus in ES cells. | 2.02e-05 | 2 | 157 | 2 | 18283123 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 34463738 | ||
| Pubmed | Differential expression of Oct3/4 in human breast cancer and normal tissues. | 2.02e-05 | 2 | 157 | 2 | 29620155 | |
| Pubmed | Glutamine Metabolism Regulates the Pluripotency Transcription Factor OCT4. | 2.02e-05 | 2 | 157 | 2 | 27346346 | |
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 2.02e-05 | 2 | 157 | 2 | 1317301 | |
| Pubmed | Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming. | 2.02e-05 | 2 | 157 | 2 | 26877091 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 12615074 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 22367590 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 22739622 | ||
| Pubmed | Oct-4: more than just a POUerful marker of the mammalian germline? | 2.02e-05 | 2 | 157 | 2 | 9524569 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 25748933 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 31439038 | ||
| Pubmed | Expression pattern of Oct-4 in preimplantation embryos of different species. | 2.02e-05 | 2 | 157 | 2 | 11090438 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 32994224 | ||
| Pubmed | Differential regulation of centrosome integrity by DNA damage response proteins. | 2.02e-05 | 2 | 157 | 2 | 18635967 | |
| Pubmed | Networks of Transcription Factors for Oct4 Expression in Mice. | 2.02e-05 | 2 | 157 | 2 | 28731785 | |
| Pubmed | Oct-4 controls cell-cycle progression of embryonic stem cells. | 2.02e-05 | 2 | 157 | 2 | 19968627 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 23629142 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 12702663 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 10594036 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 35501657 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 26832419 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 22120493 | ||
| Pubmed | Analysis of a transgenic Oct4 enhancer reveals high fidelity long-range chromosomal interactions. | 2.02e-05 | 2 | 157 | 2 | 26435056 | |
| Pubmed | Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation. | 2.02e-05 | 2 | 157 | 2 | 9507072 | |
| Pubmed | Oct-3/4 repression accelerates differentiation of neural progenitor cells in vitro and in vivo. | 2.02e-05 | 2 | 157 | 2 | 15548425 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 36130732 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 31222057 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 9835353 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 30209362 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 34788058 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 2.02e-05 | 2 | 157 | 2 | 15249644 | |
| Pubmed | Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. | 2.02e-05 | 2 | 157 | 2 | 17525163 | |
| Pubmed | Auxin-degron system identifies immediate mechanisms of OCT4. | 2.02e-05 | 2 | 157 | 2 | 34143975 | |
| Interaction | RSRP1 interactions | 1.19e-06 | 27 | 143 | 5 | int:RSRP1 | |
| Interaction | CDH1 interactions | PAG1 SPAG1 RARS1 NEBL MINK1 MAGI3 LRRC59 POU5F1 NLRP2 MPRIP SND1 EIF4B PHACTR4 DIAPH1 MACF1 PATJ ACBD3 SNX1 VCPIP1 | 2.18e-06 | 768 | 143 | 19 | int:CDH1 |
| Interaction | WWTR1 interactions | CEP85 APEX1 ANKHD1 MPRIP RAD50 SETD2 GTF3C1 SND1 PHACTR4 PATJ USP1 SNX1 VCPIP1 | 1.01e-05 | 422 | 143 | 13 | int:WWTR1 |
| Interaction | MAGEA9 interactions | 1.81e-05 | 208 | 143 | 9 | int:MAGEA9 | |
| Cytoband | 8p23.1 | FAM90A14 MCPH1 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 9.11e-15 | 154 | 157 | 13 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A14 MCPH1 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.99e-12 | 234 | 157 | 13 | chr8p23 |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 9.81e-06 | 9 | 90 | 3 | 1203 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 5.06e-04 | 7 | 90 | 2 | 1350 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.55e-03 | 46 | 90 | 3 | 622 | |
| GeneFamily | Dyneins, cytoplasmic | 1.84e-03 | 13 | 90 | 2 | 538 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | ASXL1 IQGAP2 CNNM1 SETD2 GTF3C1 BAZ2A PHACTR4 MACF1 TAOK1 VWA3B | 7.18e-08 | 180 | 146 | 10 | M8239 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | SETX ARID4B IQGAP2 ENPP2 ST3GAL1 ANKHD1 KIF3A RAD50 CCNL1 TMF1 SCAF11 CPLANE1 USP1 DYNC1I1 ENOX2 | 4.16e-06 | 656 | 146 | 15 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MOK ASXL1 SETX BMERB1 STK10 SETD2 RCOR1 AFAP1 DLC1 STAU2 NAV3 RBM6 MACF1 TAF4 DMD CDH2 ACBD3 | 6.03e-06 | 856 | 146 | 17 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | PAG1 SETX SAMD9 ARID4B ASH1L SPOCK2 CPA3 ST3GAL1 CGGBP1 JAK1 STK10 SETD2 GIMAP8 ZNF655 EIF4B CCNL1 DIAPH1 TMF1 MACF1 TAOK1 CARD11 SCAF11 USP1 | 8.68e-06 | 1492 | 146 | 23 | M40023 |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | CCDC60 SPAG1 DYNC2H1 DZIP1L AK9 KIF3A LRRIQ1 CFAP221 MACF1 VWA3B SPAG17 CPLANE1 | 1.07e-05 | 459 | 146 | 12 | M39136 |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD11B_DC_DN | 1.23e-05 | 191 | 146 | 8 | M9973 | |
| Coexpression | GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_UP | 1.32e-05 | 193 | 146 | 8 | M6505 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 1.54e-05 | 197 | 146 | 8 | M7403 | |
| Coexpression | BENPORATH_SOX2_TARGETS | ARID4B NEBL RASGRF2 ENPP2 APEX1 PGM2L1 POU5F1 ANKHD1 NMU RRS1 MDC1 TAF12 CDH2 SNX1 KIF2C | 1.58e-05 | 734 | 146 | 15 | M3835 |
| Coexpression | GSE11057_PBMC_VS_MEM_CD4_TCELL_DN | 1.59e-05 | 198 | 146 | 8 | M3121 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | MOK ASH1L PGM2L1 ANKHD1 MFN1 KIF3A JAK1 SETD2 RCOR1 AFAP1 CLK2 MACF1 SCAF11 ONECUT3 CLSPN CPLANE1 TAF12 USP1 ACBD3 ZFP62 UTP14C | 7.12e-08 | 780 | 144 | 21 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | MOK DYNC2H1 DZIP1L AK9 LRRC9 LRRIQ1 CFAP221 VWA3B DMD SPAG17 CPLANE1 | 5.60e-11 | 197 | 146 | 11 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | MOK MAP1A DYNC2H1 DZIP1L AK9 KIF3A LRRIQ1 CFAP221 DIAPH2 VWA3B SPAG17 | 5.91e-11 | 198 | 146 | 11 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | MOK DYNC2H1 DZIP1L AK9 LRRC9 LRRIQ1 CFAP221 VWA3B SPAG17 CPLANE1 | 2.44e-10 | 169 | 146 | 10 | fba841664939c771881ba97f14ef1df6635c04ff |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | MOK SPAG1 MAP1A DYNC2H1 DZIP1L LRRIQ1 CFAP221 DIAPH2 VWA3B SPAG17 | 1.09e-09 | 197 | 146 | 10 | 71fea4aa6ce96c7693fa94792d08770622873850 |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.27e-08 | 188 | 146 | 9 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.52e-08 | 192 | 146 | 9 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.59e-08 | 193 | 146 | 9 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.74e-08 | 195 | 146 | 9 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.82e-08 | 196 | 146 | 9 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.90e-08 | 197 | 146 | 9 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.90e-08 | 197 | 146 | 9 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.90e-08 | 197 | 146 | 9 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 1.98e-08 | 198 | 146 | 9 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.07e-08 | 199 | 146 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.15e-08 | 157 | 146 | 8 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-07 | 179 | 146 | 8 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.90e-07 | 186 | 146 | 8 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-07 | 190 | 146 | 8 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-07 | 190 | 146 | 8 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.42e-07 | 192 | 146 | 8 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | multiciliated|World / shred by cell class for turbinate | 2.42e-07 | 192 | 146 | 8 | 0f89ea0deb651ca11531c51ee94e0233608d22ea | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.42e-07 | 192 | 146 | 8 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.52e-07 | 193 | 146 | 8 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.52e-07 | 193 | 146 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.52e-07 | 193 | 146 | 8 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.62e-07 | 194 | 146 | 8 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.62e-07 | 194 | 146 | 8 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.62e-07 | 194 | 146 | 8 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-07 | 194 | 146 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.73e-07 | 195 | 146 | 8 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 2.73e-07 | 195 | 146 | 8 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-07 | 195 | 146 | 8 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-07 | 195 | 146 | 8 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 2.73e-07 | 195 | 146 | 8 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-07 | 195 | 146 | 8 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-07 | 195 | 146 | 8 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.73e-07 | 195 | 146 | 8 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 2.73e-07 | 195 | 146 | 8 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-07 | 195 | 146 | 8 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 2.83e-07 | 196 | 146 | 8 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.83e-07 | 196 | 146 | 8 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.83e-07 | 196 | 146 | 8 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 2.83e-07 | 196 | 146 | 8 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.30e-07 | 200 | 146 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 1.35e-06 | 167 | 146 | 7 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-06 | 168 | 146 | 7 | d8f485f8459532a2cb0bef899e6569142cf75685 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-06 | 169 | 146 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.52e-06 | 170 | 146 | 7 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-06 | 172 | 146 | 7 | 0fc692be845d4225ff8b63bf9195724fc8510c2c | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-06 | 176 | 146 | 7 | 9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-06 | 176 | 146 | 7 | bb41e9478373726eb460af764de0277b2d09928e | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-06 | 176 | 146 | 7 | ea27e18407b8a13e8212830da859efeb8f158690 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-06 | 176 | 146 | 7 | bfbab3c5b738b3b0b1540f2059d0245fbd8c0031 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.14e-06 | 179 | 146 | 7 | ecea75c568911ff56939c9f67ab901497bd4356c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-06 | 181 | 146 | 7 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 2.38e-06 | 182 | 146 | 7 | 6e35892fa959ee31591850ded8f1088195ddeb01 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-06 | 182 | 146 | 7 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.38e-06 | 182 | 146 | 7 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.47e-06 | 183 | 146 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.66e-06 | 185 | 146 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.66e-06 | 185 | 146 | 7 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.85e-06 | 187 | 146 | 7 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.96e-06 | 188 | 146 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 2.96e-06 | 188 | 146 | 7 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 3.06e-06 | 189 | 146 | 7 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.06e-06 | 189 | 146 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.17e-06 | 190 | 146 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.17e-06 | 190 | 146 | 7 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.17e-06 | 190 | 146 | 7 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 3.17e-06 | 190 | 146 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.28e-06 | 191 | 146 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.51e-06 | 193 | 146 | 7 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.64e-06 | 194 | 146 | 7 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.64e-06 | 194 | 146 | 7 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.64e-06 | 194 | 146 | 7 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 3.64e-06 | 194 | 146 | 7 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.76e-06 | 195 | 146 | 7 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.76e-06 | 195 | 146 | 7 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.76e-06 | 195 | 146 | 7 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.76e-06 | 195 | 146 | 7 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-06 | 195 | 146 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.89e-06 | 196 | 146 | 7 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.02e-06 | 197 | 146 | 7 | 479841809554a9d0b1e4f23da6e657392b0f4971 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 4.02e-06 | 197 | 146 | 7 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.02e-06 | 197 | 146 | 7 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.02e-06 | 197 | 146 | 7 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.02e-06 | 197 | 146 | 7 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-06 | 197 | 146 | 7 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 4.02e-06 | 197 | 146 | 7 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.02e-06 | 197 | 146 | 7 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 4.16e-06 | 198 | 146 | 7 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 4.30e-06 | 199 | 146 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.44e-06 | 200 | 146 | 7 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.44e-06 | 200 | 146 | 7 | cded40d5069a6fdbd90ac9a2a0bbef11727b28d5 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.44e-06 | 200 | 146 | 7 | 7cb3e3bd9e851ccb096e0a3471819471d85ebace | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 4.44e-06 | 200 | 146 | 7 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal|3m / Sample Type, Dataset, Time_group, and Cell type. | 4.44e-06 | 200 | 146 | 7 | ce012d738cbec1afdd6af0e10e94b2b6c17b036e | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.44e-06 | 200 | 146 | 7 | e0cec0a844b7c1f8edee4c005af27766754e470a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Cilia-bearing_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 4.44e-06 | 200 | 146 | 7 | 0d14a950172a56b11fdebee8f4e13b0c10e0d592 | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; HL60; HG-U133A | 5.49e-06 | 198 | 146 | 9 | 1377_UP | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; PC3; HT_HG-U133A | 5.72e-06 | 199 | 146 | 9 | 6355_UP | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.30e-05 | 10 | 143 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.30e-05 | 10 | 143 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.37e-05 | 12 | 143 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Intellectual Disability | RARS1 ASH1L SHROOM4 SETD2 SCN1A DIAPH1 MACF1 TAOK1 CDH2 ZMYM6 | 6.85e-05 | 447 | 143 | 10 | C3714756 |
| Disease | autosomal dominant auditory neuropathy 1 (implicated_via_orthology) | 6.97e-05 | 3 | 143 | 2 | DOID:0060690 (implicated_via_orthology) | |
| Disease | mastiha supplement exposure measurement, interleukin-6 measurement | 1.39e-04 | 4 | 143 | 2 | EFO_0004810, EFO_0600067 | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 2.31e-04 | 5 | 143 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement | CCDC60 MAP1A CCDC168 JAK1 BICDL1 RGS6 PXDN KCND3 ZNF655 DNAH17 CCNL1 MACF1 SCAF11 TAF4 TAF4B PATJ | 2.57e-04 | 1206 | 143 | 16 | EFO_0004458 |
| Disease | cortical surface area measurement | CNBD1 SAMD9 MCPH1 IQGAP2 ENPP2 RASGEF1A CPA3 FRMD4B MPRIP AFAP1 LRRIQ1 SND1 MDC1 STAU2 NAV3 MACF1 SPAG17 | 2.88e-04 | 1345 | 143 | 17 | EFO_0010736 |
| Disease | Seizure, Febrile, Simple | 4.82e-04 | 7 | 143 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 4.82e-04 | 7 | 143 | 2 | C0751057 | |
| Disease | optic disc size measurement | 5.07e-04 | 205 | 143 | 6 | EFO_0004832 | |
| Disease | Embryonal Rhabdomyosarcoma | 6.41e-04 | 8 | 143 | 2 | C0206656 | |
| Disease | endometrial cancer (is_implicated_in) | 7.08e-04 | 36 | 143 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | Febrile Convulsions | 8.21e-04 | 9 | 143 | 2 | C0009952 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 8.21e-04 | 9 | 143 | 2 | C3502809 | |
| Disease | Neurodevelopmental Disorders | 1.11e-03 | 93 | 143 | 4 | C1535926 | |
| Disease | rectum cancer | 1.11e-03 | 42 | 143 | 3 | EFO_1000657 | |
| Disease | Charcot-Marie-Tooth Disease | 1.49e-03 | 12 | 143 | 2 | C0007959 | |
| Disease | total blood protein measurement | 1.61e-03 | 449 | 143 | 8 | EFO_0004536 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.76e-03 | 13 | 143 | 2 | C0751122 | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 1.76e-03 | 13 | 143 | 2 | C0270914 | |
| Disease | pimelic acid measurement, 3-methyladipic acid measurement | 2.04e-03 | 14 | 143 | 2 | EFO_0010449, EFO_0010524 | |
| Disease | obsolete_interleukin-12 subunit B measurement | 2.04e-03 | 14 | 143 | 2 | EFO_0010787 | |
| Disease | pathological myopia | 2.12e-03 | 111 | 143 | 4 | EFO_0004207 | |
| Disease | MMR-related febrile seizures | 2.35e-03 | 15 | 143 | 2 | EFO_0006519 | |
| Disease | sleep apnea measurement | 2.49e-03 | 116 | 143 | 4 | EFO_0007817 | |
| Disease | ureidopropionic acid measurement | 2.68e-03 | 16 | 143 | 2 | EFO_0010542 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 2.68e-03 | 16 | 143 | 2 | C0393706 | |
| Disease | Prostatic Neoplasms | 3.19e-03 | 616 | 143 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.19e-03 | 616 | 143 | 9 | C0376358 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 3.27e-03 | 61 | 143 | 3 | C1961102 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 3.39e-03 | 18 | 143 | 2 | HP_0002373 | |
| Disease | Global developmental delay | 4.07e-03 | 133 | 143 | 4 | C0557874 | |
| Disease | Eczema | 4.12e-03 | 310 | 143 | 6 | HP_0000964 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EKEVNIKKPEDNENL | 486 | Q4LE39 | |
| RKKQKPLPEEEEQEN | 1926 | Q9NR48 | |
| REAAELPQKNQRLEK | 1001 | Q8WWN8 | |
| RLEINVLEKINEKDP | 206 | P49760 | |
| VLEKINEKDPDNKNL | 211 | P49760 | |
| NKTDNRPLKKLEAQE | 686 | Q9UIF9 | |
| KPQAILEEKLKQLEE | 606 | Q8N556 | |
| LRKDKIIFPNDENVK | 276 | Q7Z5M8 | |
| KAEFEEQNVRKKQRP | 71 | Q9UFW8 | |
| EDNKQEENKENRKRP | 111 | P20930 | |
| QKKQTENPKELDERV | 1531 | P11532 | |
| EEIDLRNPKGNKKNA | 216 | P27695 | |
| INVKTVKKEPEDRQQ | 356 | Q9UK58 | |
| NEEKQQPLREKDIII | 106 | O60610 | |
| RAANEEETKNKPKLN | 31 | O60879 | |
| KEPKEQLQKAIRDRD | 461 | Q6ZP65 | |
| LNKDKGEKEERPRQQ | 96 | A6NDY2 | |
| PQETVDQEPKDQKRK | 511 | Q8IXJ9 | |
| LQKLKEEERNKFQPA | 86 | Q8IWA6 | |
| EEEEETKNPKQKIAQ | 206 | Q9UKA8 | |
| NPIDIEVDQNKESKK | 271 | Q9UKL0 | |
| DLKEKEIPELRNKLQ | 741 | Q92878 | |
| DLKKQPLQDVAKRVE | 371 | P49758 | |
| NKLEEQNPDIVSEKK | 846 | P23458 | |
| LNKDKGEKEERPRQQ | 96 | A6NKC0 | |
| NDQKCKLQKLPEERV | 271 | Q6ZRR7 | |
| ARLPKEIDQLEKIQN | 696 | Q8IWA4 | |
| GKQKKQEQPVEEVLE | 196 | Q8IYY4 | |
| KEKLEQNPEKSQDIK | 126 | Q06416 | |
| LNKDKGEKEERPRQQ | 96 | A8MXZ1 | |
| PADKNKRQDELIVLN | 31 | Q9UK17 | |
| PEVLENQEKEDLLKK | 1731 | Q14667 | |
| PNAQRVKKDEKEQIK | 156 | Q9NSB2 | |
| EKTKQDLKAEEQQLP | 271 | Q6WCQ1 | |
| QKDKALEPKDKDLEQ | 1466 | P78559 | |
| IQLEKDQPLVKERDN | 256 | Q14676 | |
| QFENPVEEAKRKKQL | 366 | Q5TCQ9 | |
| KELQRQKTNLDDDVP | 136 | Q8NEM0 | |
| KPQEQDEKDNTKRFL | 91 | P48645 | |
| QEAVKDLPQEKQKTR | 1396 | Q6PRD1 | |
| REQEKKPKKEANQAP | 211 | Q96AG4 | |
| VKILKNEANDPALKD | 401 | P43405 | |
| KQELQNLVAIPEKEK | 91 | Q96MC5 | |
| KVHREDDPNKEQQLK | 441 | Q16206 | |
| ERPAQNEKRKEKNIK | 41 | P52272 | |
| NQDKKQEVKEAPPRE | 201 | O14576 | |
| NNEIEKKRNLIPTDK | 5561 | Q5CZC0 | |
| LNKDKGEKEERPRQQ | 96 | A8MWA6 | |
| LNKDKGEKEERPRQQ | 96 | P0C7W9 | |
| DKNPKTKEQIENLLR | 36 | Q6PCE3 | |
| SLLQPKEKEEKNRDK | 461 | Q8IVL0 | |
| TRPQIKDFKEKIQQD | 376 | Q9H3P7 | |
| ELNKLLEEIEEKNPQ | 1026 | Q9NX02 | |
| KQKQSLKQEEDRPKR | 326 | Q9UQ07 | |
| LNKDKGEKEERPRQQ | 96 | P0DV74 | |
| KNKARINEDPKDALL | 346 | Q9Y496 | |
| LNKDKGEKEERPRQQ | 96 | P0DV73 | |
| QQEDQKKEVPKRILD | 386 | Q8IZ21 | |
| PKNEADRQAEKREIK | 606 | Q8IZ21 | |
| KQIFRKPQQKLGDED | 806 | P09884 | |
| LNKDKGEKEERPRQQ | 96 | P0DV76 | |
| PLQELKSDAQKEEKI | 526 | Q96JM4 | |
| KERNPNIDALKVINK | 2091 | Q9UPN3 | |
| KEKLEQNPEESQDIK | 126 | Q01860 | |
| NPEEKKQKILDIRKN | 71 | P38405 | |
| LNKDKGEKEERPRQQ | 96 | A6NJQ4 | |
| QKLVEAAKKLANEPD | 511 | Q9Y2L6 | |
| KNKIDDELKEVQPLV | 2971 | Q8NCM8 | |
| EKPDLEEQKTKLLQQ | 3411 | Q8NCM8 | |
| PQDEKQADIIKDLAK | 31 | P15088 | |
| NDDSEIIKKPKEQQE | 2501 | Q9H799 | |
| VVAKERPDLEQLKAN | 3566 | Q9UFH2 | |
| DPEKQKAPQKLNVEE | 3066 | Q8N3K9 | |
| SLENDNQPKKRKAEE | 1056 | Q6ZRK6 | |
| NQPKKRKAEETLEKN | 1061 | Q6ZRK6 | |
| QELKQKQLKEAEGPL | 351 | Q9HC77 | |
| QKPDVIKRKLEEVQQ | 721 | Q6P2H3 | |
| QEVQELLKDRDPKEI | 356 | Q9HCS2 | |
| DDLLQDFIEKNKPLK | 141 | Q8ND71 | |
| DFIEKNKPLKQLVQD | 146 | Q8ND71 | |
| EPEDLALQLQQKEKD | 46 | A1A5D9 | |
| PQELQEKKIQVLEEK | 176 | Q9BXX0 | |
| DVKNEKQHIPQKEER | 5356 | Q8NDH2 | |
| LNKDKGEKEERPRQQ | 96 | A6NIJ5 | |
| ATPKQAEQEEKQKQR | 896 | A6NE01 | |
| FPENQKEEIKAPKRN | 451 | Q8IXS0 | |
| LNKDKGEKEERPRQQ | 96 | A8MXJ8 | |
| KNDPEKQNENTRKEK | 986 | Q99590 | |
| KLPKEREELEQAQIK | 446 | Q9HBR0 | |
| RPLNKQELAKKEIDV | 266 | Q99661 | |
| LKLKNDIENRPKKEQ | 251 | Q9BXL7 | |
| DIENRPKKEQVLELE | 256 | Q9BXL7 | |
| KERQAKQLLIDPEDD | 751 | P19022 | |
| DKVEPKNKLDELNKR | 571 | Q13822 | |
| LNKDKGEKEERPRQQ | 96 | P0C7X0 | |
| NEDPNNKLIRELKDE | 361 | Q12756 | |
| PQLIVQKELDREEKD | 231 | Q9BZA8 | |
| QKEQEKLQRQLDEPK | 381 | P23588 | |
| RKEQEQQKERALQPK | 401 | O60422 | |
| RNKILHNDPEVEKKQ | 1091 | Q8N4C8 | |
| IRKEKEVKDQAQPAE | 801 | Q4G0U5 | |
| KTKEQKVNPREIAEN | 126 | P54136 | |
| SNKEDPEQLRLKQKA | 756 | Q92750 | |
| QEDPEQLRLKQKAKE | 976 | O00268 | |
| KVEEENTKKQLPEVQ | 1066 | Q5TCS8 | |
| AQPQKREEQTKKENE | 931 | P78332 | |
| EKKPQLTQEELEAKQ | 636 | Q12872 | |
| QRAAELELEKKQEPN | 226 | Q8IUE1 | |
| NDTIEEPNKVQKRKR | 161 | Q93075 | |
| EINEKLRPQLAEKKQ | 561 | Q5TAG4 | |
| QSNQEDEDPDIKKIK | 196 | O14827 | |
| KPVEKLKDQLREVLQ | 1406 | Q5K651 | |
| KKLQDLVREVDPNEQ | 61 | Q16514 | |
| EDAQLPLEQKKRKIQ | 1361 | Q13576 | |
| LNKDKGEKEERPRQQ | 96 | A8MX19 | |
| LNKDKGEKEERPRQQ | 96 | A6NNJ1 | |
| LNKDKGEKEERPRQQ | 96 | P0C7W8 | |
| LNKDKGEKEERPRQQ | 96 | D6RGX4 | |
| EKKKEPEPNFQLLDN | 866 | Q99460 | |
| REKKPNNLNDTIKEL | 106 | Q11201 | |
| NVLPKEKQLKNEELV | 861 | Q7Z333 | |
| AKEEKPKNDQEPVNR | 461 | Q5VXU9 | |
| VAKAELLNKLKDQPE | 1281 | Q9ULL8 | |
| PRLEGENTQDKNKKL | 376 | Q7KZF4 | |
| LKEELNENQSTPKKE | 566 | Q7L7X3 | |
| EKDNEPEIQPAQKKL | 366 | Q96JS3 | |
| PVKLLDENENLQEKE | 261 | Q9NWQ8 | |
| RKQSLGKPDQKDLNE | 1251 | Q96QB1 | |
| LNKDKGEKEERPRQQ | 96 | P0C7V4 | |
| LKEQEIEDQKNPRKA | 221 | O15269 | |
| QQRRENEKKVIEDKP | 141 | Q6Q759 | |
| KQKILDEIKPLDDLN | 1041 | P35498 | |
| EPQNADKIKIKIADL | 396 | Q9UPE1 | |
| ALKDPEQKVLKIQND | 176 | Q9BY15 | |
| PLNKDKIEELKKNRE | 811 | Q8IWZ3 | |
| EQKRKQEEDEENKPK | 1466 | Q8IWZ3 | |
| LPKLFKQEEQRELNE | 81 | Q8NA66 | |
| ELEIQEKQKQSDIRP | 406 | Q9HAW4 | |
| PNVIQELKFDEKNKK | 641 | Q9NRU3 | |
| DDLELQPAKKRQKAV | 91 | Q6P3X8 | |
| DEALQRVNKKVEALP | 1461 | Q9BXT8 | |
| NQNDELEEKVKEIPK | 1026 | P82094 | |
| NNRPDAPKEKKEKEQ | 541 | Q5TAP6 | |
| APKEKKEKEQLINLQ | 546 | Q5TAP6 | |
| EQKQQLEAGPEKAKL | 96 | Q8N9B8 | |
| QPLFRKLKNELNEDE | 46 | Q8N427 | |
| NKPDKLQQAKDEILE | 441 | Q13596 | |
| RLAQIQQAKKEKEPD | 311 | Q9NUL3 | |
| QDELFKKEENIKDLP | 971 | Q0IIM8 | |
| KNDNIQALEKLEKVP | 506 | Q8NI35 | |
| KQRPEQKIEDISNKV | 1141 | O94759 | |
| PLEDQFAKRIQAKKE | 166 | Q15050 | |
| PFNKEKERRKIEIQE | 746 | Q07617 | |
| KKEVKNEVEKLPRQQ | 661 | O94804 | |
| PEVVEEIKQKQKAQD | 161 | Q8N2K1 | |
| LNKDKGEKEERPRQQ | 96 | Q658T7 | |
| EDLKNEIKNPEIREK | 1186 | Q92626 | |
| EQRIAEEKAKRPKQE | 26 | Q99250 | |
| LDEIKPLEDLNNKKD | 1036 | Q99250 | |
| QLDPDLVEAQRKKLQ | 1096 | Q96JH7 | |
| RERDPDKQTQNKEKR | 2061 | Q9BYW2 | |
| EENKLLIPKQKISEE | 51 | Q8N720 | |
| KAVVPQQELLDKIKE | 11 | O95789 | |
| DSKVENQQKKPVENR | 46 | Q8NB50 | |
| EDCQKKPQLLEQTKR | 486 | Q9UI33 | |
| AKDERKRLAQQNPDL | 96 | P35713 | |
| LSQEEKEKLDANKPI | 941 | Q502W6 | |
| KVDNLEEFLNDPLKK | 926 | Q12789 | |
| LQQKEEQLLGEEPEK | 966 | Q07283 | |
| QLLKKEEVKNVAELP | 216 | O94782 | |
| ELERIQIQEAAKKKP | 316 | Q92563 | |
| PEKIQDFNDEKEKLL | 91 | Q5THJ4 | |
| LNKDKGEKEERPRQQ | 96 | P0DV75 | |
| KDSPEIERVKKNQQN | 606 | O76041 |